Access Pain Solutions | Tulsa Pain Management Doctor
4750 South Garnett Road, Tulsa
4.8(2667 Google reviews)
United States
9 listed treatment centers serving Tulsa and the surrounding area.
4750 South Garnett Road, Tulsa
4.8(2667 Google reviews)
For people in Tulsa considering SPRAVATO®, costs depend on insurance benefits, the treatment setting, and the prescribed schedule. Both the medication and the supervised treatment visit, including observation and monitoring, may be billed. Ask for an estimate that includes both rather than assuming a medication copay represents the full visit cost.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials before deciding whether to approve treatment. Ask the center which records it needs, such as medication names, treatment dates, and notes about response or side effects. Your previous prescribers may be able to help gather this information. Authorization does not necessarily mean every charge will be paid in full.
Medicare may cover Spravato through Part B or Part D depending on the plan and setting. Oklahoma Medicaid coverage also depends on the applicable plan and requirements. Neither coverage nor a center’s participation should be assumed; verify both directly.
Manufacturer savings programs exist for eligible commercially insured patients, but they are not for people using government insurance. Ask about current eligibility rules and which charges a program may help with.
Before starting, ask the center and insurer:
There is no listed SPRAVATO® treatment center in Tulsa yet on this city page. The supplied directory summary includes an Owasso listing, but its REMS certification is not confirmed. You can ask about treatment there, while verifying current availability and certification directly. A directory listing alone does not establish that a location is authorized to administer Spravato.
Treatment happens only in a REMS-certified healthcare setting. You self-administer the nasal spray under direct observation of a healthcare provider; it is never sent home with you. Monitoring continues for at least two hours after each dose, so allow additional time for check-in, preparation, and any longer observation your care team considers necessary.
For treatment-resistant depression, the typical labeled schedule begins twice weekly for weeks 1–4, then weekly for weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber individualizes the schedule; do not assume this will be your exact appointment pattern.
Arrange a driver for every visit. You must not drive or operate machinery until the next day after a restful sleep. Ask the center about its transportation and pickup requirements before relying on a taxi or rideshare. Consider a backup ride if your usual driver becomes unavailable.
When planning time off work, include travel, the full visit, and recovery afterward. Discuss scheduling options with the center, especially if your job involves driving or machinery. If local appointments are unavailable, ask your prescriber for help locating a REMS-certified setting and coordinating records before you commit to travel.
This city page currently has no listed SPRAVATO® treatment center in Tulsa. The directory summary includes an Owasso listing, but its REMS certification is unconfirmed. Ask any prospective location whether it is currently REMS-certified and accepting patients for evaluation. Your prescriber can also help you locate a certified setting; a listing does not establish certification.
Spravato is approved for adults with treatment-resistant depression, alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must assess your diagnosis, treatment history, and safety considerations before recommending it.
Coverage depends on your plan and the treatment setting. Prior authorization and documentation of earlier antidepressant trials are common requirements. Medicare and Oklahoma Medicaid may cover treatment under applicable plan rules, but coverage is not guaranteed. Ask your insurer and the center to verify network status, medication benefits, monitoring charges, and your expected share before scheduling.
You use the nasal spray yourself while a healthcare provider directly observes you in a REMS-certified setting. After each dose, staff monitor you for at least two hours for effects such as sedation, dissociation, breathing problems, and increased blood pressure. Allow extra time beyond monitoring. You need someone else to take you home; the medication never goes home with you.
Spravato has boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. Blood pressure can also increase. It is a Schedule III controlled substance. Discuss your health history and medications with the prescriber, and report concerning symptoms during monitoring. Do not drive or operate machinery until the next day after a restful sleep.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. Do not wait for a treatment appointment during a crisis. Call or text 988 for immediate crisis support, or call 911 if there is immediate danger or a medical emergency.
Approved uses, nearby treatment centers, and medically sourced patient guides.